1. Duus AH, Hannibal CG, Baandrup L, Zheng G, Galanakis M, Maltesen T, Hertzum-Larsen R, Mørch LS, Kjær SK. Prediagnostic use of menopausal hormone therapy and long-term survival of localized epithelial ovarian cancer: The Extreme study. Int J Cancer. 2024 Jul 1;155(1):19-26.
2. Christensen J, Trabjerg B, Dreier JW. Correlation of drug dose estimated from national prescription registers with mean blood level of antiseizure medication in pregnancy. Pharmacoepidemiol Drug Saf. 2024 Jun;33(6):e5811.
3. Andersen MA, Gregersen R, Petersen TS, Wang JN, Petersen J, Jimenez-Solem E. Association Between First-time Neurologic Events and Metronidazole Treatment: A Case-time Control Study. Clin Ther. 2024 Apr;46(4):307-312.
4. Østergaard L, Olesen JB, Petersen JK, Nielsen LS, Kristensen SL, Schou M, Køber L, Fosbøl E. Arterial Thromboembolism in Patients With Atrial Fibrillation and CHA2DS2-VASc Score 1: A Nationwide Study. Circulation. 2024 Mar 5;149(10):764-773.
5. Rosenqvist TW, Wium-Andersen MK, Wium-Andersen IK, Jørgensen MB, Osler M. Long-Term Use of Benzodiazepines and Benzodiazepine-Related Drugs: A Register-Based Danish Cohort Study on Determinants and Risk of Dose Escalation. Am J Psychiatry. 2024 Mar 1;181(3):246-254.
6. Mejldal A, Nielsen PAS, Finn SW. Seasonal variations in treatment seeking for Alcohol Use Disorder in the total Danish population. J Stud Alcohol Drugs. 2024 Mar 1. doi: 10.15288/jsad.23-00269. Epub ahead of print. PMID: 38426666.
7. Johansson MS, Pottegård A, Søndergaard J, Englund M, Grønne DT, Skou ST, Roos EM, Thorlund JB. Use of prescribed analgesics before and after exercise therapy and patient education in patients with knee or hip osteoarthritis. Rheumatol Int. 2024 Feb;44(2):319-328.
8. Nemeth B, Smeets M, Pedersen AB, Kristiansen EB, Nelissen R, Whyte M, Roberts L, de Lusignan S, le Cessie S, Cannegieter S, Arya R. Development and validation of a clinical prediction model for 90-day venous thromboembolism risk following total hip and total knee arthroplasty: a multinational study. J Thromb Haemost. 2024 Jan;22(1):238-248.
9. Harbi H, Pottegård A. Validation of the "Indication for Use" (INDO) Variable in the Danish National Prescription Registry. Epidemiology. 2024 Jan 1;35(1):1-6.
10. Pottegård A, Schmidt SAJ, Wallach-Kildemoes H, Sørensen HT, Hallas J, Schmidt M. Data Resource Profile: The Danish National Prescription Registry. Int J Epidemiol. 2017 Jun 1;46(3):798-798f.